[Changes in the clinical and immunological indices of patients with disseminated sclerosis being treated with prednisolone]. / Izmenenie klinicheskikh i immunologicheskikh pokazatelei u bol'nykh rasseiannym sklerozom pri lechenii prednizolonom.

The authors examined clinically and immunologically 60 patients with multiple sclerosis. One group (30 patients) received prednisolone in the complex treatment while the second group (30 patients) received only complex treatment. A control group of 20 healthy persons was examined. Patients of the first group showed marked neurological and immunological disorders which is considered as a complication due to the empiric prednisolone doses.

[The prevalence of disseminated sclerosis in the Carpathian region]. / Rasprostranennost' rasseiannogo skleroza v Karpatskom regione.

The authors investigated the incidence of multiple sclerosis in the Carpathian region. It is concluded on the basis of a statistical analysis that the incidence of multiple sclerosis in this region is influenced by environmental factors.